SOPHIRIS BIO INC's ticker is SPHS and the CUSIP is 83578Q209. A total of 24 filers reported holding SOPHIRIS BIO INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $1,036,000 | -23.5% | 353,686 | -41.6% | 0.01% | -33.3% |
| Q2 2014 | $1,355,000 | -45.9% | 605,142 | -19.5% | 0.01% | -43.8% |
| Q1 2014 | $2,503,000 | -32.4% | 751,842 | -24.9% | 0.02% | -33.3% |
| Q4 2013 | $3,701,000 | -21.0% | 1,000,500 | 0.0% | 0.02% | -27.3% |
| Q3 2013 | $4,682,000 | – | 1,000,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 494,000 | $1,062,000 | 0.08% |
| Rock Springs Capital Management LP | 490,000 | $1,054,000 | 0.08% |
| Acrospire Investment Management LLC | 14,711 | $32,000 | 0.02% |
| FNY Managed Accounts LLC | 7,556 | $16,245,000 | 0.02% |
| Schonfeld Strategic Advisors LLC | 20,883 | $45,000 | 0.01% |
| Airain ltd | 32,017 | $69,000 | 0.00% |
| Virtu KCG Holdings LLC | 17,013 | $37,000 | 0.00% |
| Bank of New York Mellon Corp | 18,866 | $41,000 | 0.00% |
| Citadel Advisors | 49,176 | $106,000 | 0.00% |
| MORGAN STANLEY | 225 | $0 | 0.00% |